These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1618483)

  • 1. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
    Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
    Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a mannose-specific endocytosis receptor from human placenta.
    Lennartz MR; Cole FS; Shepherd VL; Wileman TE; Stahl PD
    J Biol Chem; 1987 Jul; 262(21):9942-4. PubMed ID: 3611070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of tissue-type plasminogen activator by the mannose receptor.
    Otter M; Barrett-Bergshoeff MM; Rijken DC
    J Biol Chem; 1991 Jul; 266(21):13931-5. PubMed ID: 1906888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
    Narita M; Bu G; Herz J; Schwartz AL
    J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
    Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver.
    Otter M; Kuiper J; van Berkel TJ; Rijken DC
    Ann N Y Acad Sci; 1992 Dec; 667():431-42. PubMed ID: 1339243
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor.
    Noorman F; Barrett-Bergshoeff MM; Rijken DC
    Eur J Biochem; 1998 Jan; 251(1-2):107-13. PubMed ID: 9492274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
    Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
    Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
    Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
    Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
    Lansink M; Jong M; Bijsterbosch M; Bekkers M; Toet K; Havekes L; Emeis J; Kooistra T
    Blood; 1999 Aug; 94(4):1330-6. PubMed ID: 10438721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
    Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
    Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a mannose receptor from human pigment epithelium.
    Shepherd VL; Tarnowski BI; McLaughlin BJ
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1779-84. PubMed ID: 2032800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
    Rijken DC; Otter M; Kuiper J; van Berkel TJ
    Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.
    Smedsrød B; Einarsson M; Pertoft H
    Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
    Stang E; Roos N; Schlüter M; Berg T; Krause J
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
    Noorman F; Braat EA; Rijken DC
    Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative receptor assay using Triton X-114 for plasminogen activator binding proteins in solubilized membranes from human liver and placenta.
    Nguyen G; Kruithof EK
    Anal Biochem; 1993 Feb; 208(2):277-82. PubMed ID: 8383929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of the human alveolar macrophage mannose receptor.
    Stephenson JD; Shepherd VL
    Biochem Biophys Res Commun; 1987 Oct; 148(2):883-9. PubMed ID: 3689377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.